NMPA Approval

Human Hepatitis B Immunoglobulin（pH4）for Intravenous Injection

Approval Number

国药准字S20083007

Company远大蜀阳生命科学（成都）有限公司

Registration Date

April 18, 2022

Drug Information

Generic Name

静注乙型肝炎人免疫球蛋白(pH4)

Dosage Form

注射剂

Strength

每瓶含抗-HBs2000IU(40ml)

Drug Type

生物制品

Registration Date

April 18, 2022

Company Information

Applicant Company

Company Name远大蜀阳生命科学（成都）有限公司

Company Address

成都高新区安泰五路888号

Manufacturing Company

Company Name远大蜀阳生命科学（成都）有限公司

Company Address

成都高新区安泰五路888号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

静注乙型肝炎人免疫球蛋白(pH4) - NMPA 批准文号 | MedPath